ASTX..$2.71.. Flush with cash & upcoming catalysts. Could be good for the share price in the short-term. Company has a market cap of 255m and has 130m cash in the bank with no debt. They are making money as well with royalties from Dacogen.
Astex Pharmaceuticals to Present at Oppenheimer Healthcare Conference
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.